EESYR Trademark

Trademark Overview

On Friday, April 22, 2011, a trademark application was filed for EESYR with the United States Patent and Trademark Office. The USPTO has given the EESYR trademark a serial number of 85302237. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, August 2, 2023. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The EESYR trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Protein fabrication, production, and manufacture for others

Pharmaceutical research services, namely, protein and cell line development and production; genetic engineering services utilizing a collection of genetic technologies for the rapid production of cell lines; scientific, laboratory and medical research in the field of cell line engineering; scientific laboratories performing cell line development; scientific research and development, namely, development of cell lines and proteins for others
eesyr

General Information

Serial Number85302237
Word MarkEESYR
Filing DateFriday, April 22, 2011
Status800 - REGISTERED AND RENEWED
Status DateWednesday, August 2, 2023
Registration Number4280328
Registration DateTuesday, January 22, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 11, 2011

Trademark Statements

Goods and ServicesProtein fabrication, production, and manufacture for others
Goods and ServicesPharmaceutical research services, namely, protein and cell line development and production; genetic engineering services utilizing a collection of genetic technologies for the rapid production of cell lines; scientific, laboratory and medical research in the field of cell line engineering; scientific laboratories performing cell line development; scientific research and development, namely, development of cell lines and proteins for others

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, April 26, 2011
Primary Code040
First Use Anywhere DateMonday, December 31, 2007
First Use In Commerce DateMonday, December 31, 2007
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 26, 2011
Primary Code042
First Use Anywhere DateMonday, December 31, 2007
First Use In Commerce DateMonday, December 31, 2007

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Wednesday, August 2, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, August 2, 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, August 2, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, August 2, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, January 13, 2023TEAS SECTION 8 & 9 RECEIVED
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, January 22, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, February 11, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, February 11, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, February 11, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, January 11, 2019TEAS SECTION 8 & 15 RECEIVED
Monday, January 22, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 6, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 6, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 22, 2013REGISTERED-PRINCIPAL REGISTER
Saturday, December 15, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, December 14, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, December 13, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, December 13, 2012STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 4, 2012USE AMENDMENT FILED
Monday, December 10, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 4, 2012TEAS STATEMENT OF USE RECEIVED
Thursday, June 7, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 5, 2012SOU EXTENSION 1 GRANTED
Tuesday, June 5, 2012SOU EXTENSION 1 FILED
Tuesday, June 5, 2012SOU TEAS EXTENSION RECEIVED
Tuesday, December 6, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 11, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 11, 2011PUBLISHED FOR OPPOSITION
Tuesday, September 6, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 31, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 31, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 31, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 18, 2011ASSIGNED TO LIE
Wednesday, August 17, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 2, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 2, 2011NON-FINAL ACTION E-MAILED
Tuesday, August 2, 2011NON-FINAL ACTION WRITTEN
Monday, August 1, 2011ASSIGNED TO EXAMINER
Tuesday, April 26, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 26, 2011NEW APPLICATION ENTERED

Related Keywords

eesyr cell development line production scientific research engineering lines protein genetic